Bliss GVS Pharma

Sector: Healthcare

Followers

3
3
7
7
.
7
7
6
6
1
1
0.60 (0.36%)

As on 28 Jan, 2026 | 15:59

Open Trading A/c
Day Range
164.70
169.76
LH
52 Week Range
108.12
195.80
LH
Volume
* i
Bid / Ask
683,807.00
0.00 / 0.00

Bliss GVS Pharma Announcements

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Bliss GVS International PTE Ltd., Singapore, a wholly owned...

27 Jan, 2026 | 06:44pm • Source: BSE

Please find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025.

05 Jan, 2026 | 12:04pm • Source: BSE

Please find enclosed herewith an advertisement published in the Newspaper confirming the dispatch of the Postal Ballot Notice.

31 Dec, 2025 | 12:32pm • Source: BSE

Please find enclosed herewith the Postal Ballot Notice dated December 30, 2025, along with the Explanatory Statement for seeking approval of members of the Company...

30 Dec, 2025 | 04:55pm • Source: BSE

Please find enclosed herewith the intimation regarding the Closure of the Trading Window.

30 Dec, 2025 | 12:54pm • Source: BSE

Please find enclosed herewith the Intimation regarding the appointment of Mr S. N Kamath as the Managing Director of the Company.

23 Dec, 2025 | 04:36pm • Source: BSE

We would like to inform you that, the Board Meeting of the Company was held today i.e. on Tuesday, December 23, 2025, at the registered...

23 Dec, 2025 | 02:07pm • Source: BSE

We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. December 09, 2025 has approved the allotment of...

09 Dec, 2025 | 05:21pm • Source: BSE

Please find enclosed herewith the copies of newspaper advertisement published pertaining to ongoing bi-monthly communications regarding the Special Window for Re-Lodgement of Transfer Requests of...

24 Nov, 2025 | 01:04pm • Source: BSE

Please find attached herewith the newspaper publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025

10 Nov, 2025 | 12:02pm • Source: BSE

Please find attached the outcome of Nomination and Remuneration Committee Meeting held on today i.e. Thursday, November 06, 2025 with regard to Grant of 5,53,000...

06 Nov, 2025 | 09:46pm • Source: BSE

Please find attached the details of KMPs for reporting of Disclosure of Material Events to Stock Exchanges.

06 Nov, 2025 | 09:18pm • Source: BSE

Please find attached the resignation of Mr. Gagan Harsh Sharma, Managing Director of the Company with effect from November 06, 2025 along with his resignation...

06 Nov, 2025 | 09:12pm • Source: BSE

Please find attached the Resignation of Mr. Gagan Harsh Sharma, Managing Director of the Company with effect from November 06, 2025.

06 Nov, 2025 | 09:03pm • Source: BSE

Please find attached the unaudited standalone and consolidated financial results for the quarter and half yearly ended September 30, 2025.

06 Nov, 2025 | 08:54pm • Source: BSE

Please find attached herewith the Outcome of Board Meeting held on Thursday, November 06, 2025.

06 Nov, 2025 | 08:44pm • Source: BSE

We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. November 05, 2025, has approved the allotment of...

05 Nov, 2025 | 04:57pm • Source: BSE

Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider...

29 Oct, 2025 | 03:50pm • Source: BSE

We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. October 10, 2025, has approved the allotment of...

10 Oct, 2025 | 06:49pm • Source: BSE

Bliss GVS Pharma Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

07 Oct, 2025 | 11:27am • Source: NSE